Max Rosett - 31 Jan 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
EVP, OPERATIONS & INTERIM CFO
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
31 Jan 2024
Net transactions value
$0
Form type
4
Filing time
31 Jan 2024, 20:53:57 UTC
Previous filing
12 Oct 2023
Next filing
17 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +175,000 $0.000000 175,000 31 Jan 2024 Common Stock 175,000 $16.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.